About Algalr Nutrapharms Private Limited
Data last updated: 10 February 2026
Algalr Nutrapharms Private Limited is a private limited company based in Budalur Taluk, Tamil Nadu, India, a subsidiary of Camlin Fine Sciences Limited. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 24 July 2014, the company has been in operation for over 12 years.
Registered with ROC Chennai under CIN U74900TN2014PTC096649.
Capital: an authorised share capital of ₹1.15 Cr and a paid-up capital of ₹1.15 Cr. It is led by directors including Mohan Raj Subramanian and Pinakin Girishkumar Parikh.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Budalur Taluk, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.33 Cr, a growth of 125% compared to the previous year.
The company has a workforce of approximately 23 employees as per the latest available data. It operates as a subsidiary of Camlin Fine Sciences Limited.
The company is associated with 1 brand - Algalr. As per MCA filings, the company has satisfied charges of ₹1.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website algalr.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressS.No.259/1Q1 1Q2 1R1 1R2 Palayapatti – North Chithamparapatti Sengipatti – Via Manayeri, Patti Post, Budalur Taluk, Tamil Nadu, India – 613402
-
IndustryChemicals and Materials, Specialty Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Algalr Nutrapharms Private Limited
Algalr Nutrapharms Private Limited operates one associated brand: AlgalR. These brands represent Algalr Nutrapharms Private Limited's diversified market presence and brand portfolio.
Competitors & Alternatives of Algalr Nutrapharms Private Limited
Brands and companies operating in the same space as Algalr Nutrapharms Private Limited include Roquette, MVMD, DENAVA and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Roquette
|
Plant-based pharma, nutraceuticals, and cosmetics are manufactured as a CDMO. | Lestrem, France, France | 1933 |
MVMD
|
Biotech company focused on manufacturing neutraceuticals | Concord, Canada, Canada | 2005 |
DENAVA
|
Investments are managed in health and digital sectors. | Edling, Germany, Germany | 2002 |
Cortalix
|
Biotechnological company developing radiopharmaceuticals and diagnostics based on single-domain antibodies for applications in immunoPET imaging and targeted radiotherapeutics | Groningen, Netherlands, Netherlands | 2007 |
Naturacare
|
Natural health products are manufactured by Naturacare as a CDMO. | Treize-septiers, France, France | 2015 |
GMP Labs
|
Custom contract manufacturer of quality dietary supplements and homeopathic products. | Anaheim, United States, United States | 1994 |
Pillar Chemicals
|
Sports nutrition company offering products for joint health, recovery, energy, and immunity. | Chennai, India, India | 2013 |
Business Activity of Algalr Nutrapharms Private Limited
Algalr Nutrapharms Private Limited is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Algalr Nutrapharms Private Limited
Algalr Nutrapharms Private Limited is audited by ABD AND CO LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ABD AND CO LLP | blur-value | blur-value | blur-value |
Board of Directors of Algalr Nutrapharms Private Limited
Algalr Nutrapharms Private Limited is currently managed by 3 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohan Raj Subramanian | Managing Director | 24 Jul 2014 | 11 Years 11 Months | Current |
| Pinakin Girishkumar Parikh | Director | 25 May 2022 | 4 Years 1 Months | Current |
| Krishna Daulat | Director | 21 Jan 2023 | 3 Years 5 Months | Current |
Financials of Algalr Nutrapharms Private Limited FY 2025 filings available
Algalr Nutrapharms Private Limited reported revenue of ₹4.33 Cr (up 125% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Algalr Nutrapharms Private Limited
As of FY 2023, Algalr Nutrapharms Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Algalr Nutrapharms Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2016 | Small Industries Development Bank of India | ₹1.5 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Algalr Nutrapharms Private Limited
Algalr Nutrapharms Private Limited has a workforce of 23 employees as of Mar 30, 2024.
Employee Count & EPFO Data of Algalr Nutrapharms Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Algalr Nutrapharms Private Limited
GSTIN & GST Filing Data of Algalr Nutrapharms Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Algalr Nutrapharms Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Algalr Nutrapharms Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Algalr Nutrapharms Private Limited
MSME Payment Delays by Algalr Nutrapharms Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Algalr Nutrapharms Private Limited
Subsidiaries & Group Companies of Algalr Nutrapharms Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Algalr Nutrapharms Private Limited with ownership details.
MCA Filings & Documents of Algalr Nutrapharms Private Limited
MCA Filings & Documents of Algalr Nutrapharms Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Algalr Nutrapharms Private Limited
Frequently Asked Questions about Algalr Nutrapharms Private Limited
Algalr Nutrapharms Private Limited is an active private limited company in the chemicals and materials sector based in Budalur Taluk, Tamil Nadu, India. It was incorporated on 24 July 2014 (12+ years old) and is registered under CIN U74900TN2014PTC096649. The company has 23 employees.
Algalr Nutrapharms Private Limited reported revenue of ₹4.33 Cr for FY 2025 (up 125.00% YoY).
The current directors of Algalr Nutrapharms Private Limited are:
The primary industry of Algalr Nutrapharms Private Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.
Algalr Nutrapharms Private Limited can be reached at the registered office: S.No.2591Q1 1Q2 1R1 1R2 Palayapatti – North Chithamparapatti Sengipatti – Via Manayeri, Patti Post, Budalur Taluk, Tamil Nadu, India – 613402, or through the website algalr.com.
The authorised capital is ₹1.15 Cr, and the paid-up capital is ₹1.15 Cr.